Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition
Deng, Lei, Kiedrowski, Lesli A., Ravera, Elizabeth, Cheng, Haiying, Halmos, BalazsVolume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.04.007
Date:
September, 2018
File:
PDF, 638 KB
english, 2018